Bone Marrow Biopsy Value Limited in Follicular Lymphoma Response Assessment
(MedPage Today) -- Bone marrow biopsy (BMB) provided little information for response assessment in clinical trials of follicular lymphoma (FL) and should be eliminated from clinical trial requirements and diagnostic guidelines, authors of a large...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Bone Marrow Aspiration and Biopsy | Cancer & Oncology | Clinical Trials | Hematology | Lymphoma